Pfizer

COVID vaccination will probably be needed each year. This was stated by the CEO of Pfizer. Scientists believe they have found a link between the appearance of blood clots and the Astra Zeneca vaccine.

Turkey is closely following developments in the wake of the emergence of the new COVID-19 strain, Omicron, Health Minister Fahrettin Koca has said, adding that the current situation does not necessitate taking additional measures.

He recalled that Turkey immediately acted after the new variant was detected in the world and imposed travel bans on certain countries.

The number of coronavirus vaccinations in the world has exceeded 8 billion. More than half of them (4.16 billion) are in three countries - China (2.5 billion), India (1.2 billion) and the United States (0.46 billion).

The President of the European Commission Ursula von der Leyen said that the time had come for the European Union to consider mandatory vaccination of the entire population, Euronews reports.

Στις 13 Δεκεμβρίου διαθέσιμο στην Ενωση το παιδικό εμβόλιο των Pfizer/BioNTech

BioNTech has begun work on a vaccine specifically for the new variant of the coronavirus Omicron, which was first identified in South Africa.

The development of an adapted vaccine is part of the standard procedure.

The first steps for a possible new vaccine are carried out in parallel with the assessment of whether one will be needed after the advent of Omicron.

Existing coronavirus vaccines are unlikely to not work at all with the new variant Omicron. But they may work less.

This was stated by Prof. Todor Kantardzhiev on bTV. He reminded that the EC has signed an agreement with Pfizer that if a dangerous mutation of the virus occurs, the manufacturer is ready to provide an adapted vaccine in 100 days.

Will the vaccines stop the Omicron variant of the coronavirus, the New York Times asks. The new version raises new concerns, because if it turns out that the existing vaccines do not affect it, they will have to be modified, the American publication notes.

Britain has announced that it will convene an emergency meeting of G-7 health ministers tomorrow to discuss developments in the new coronavirus variant, Omicron, Reuters reported.

Biontech says it expects to have more data within two weeks to help determine whether the coronavirus vaccine, which it co-developed with Pfizer, needs to be reworked because of a new version of the coronavirus discovered in South Africa.

Pfizer and Biontech have said they expect to be able to deliver a possible new vaccine made for the new version in about 100 days, if necessary.